- Home
- GOSS vs GCTS Comparison
GOSS vs GCTS Comparison
Compare GOSS & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- GCTS
- Stock Information
- Founded
- GOSS 2015
- GCTS 1998
- Country
- GOSS United States
- GCTS United States
- Employees
- GOSS N/A
- GCTS N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- GCTS Blank Checks
- Sector
- GOSS Health Care
- GCTS Finance
- Exchange
- GOSS Nasdaq
- GCTS Nasdaq
- Market Cap
- GOSS 246.6M
- GCTS 243.2M
- IPO Year
- GOSS 2019
- GCTS N/A
- Fundamental
- Price
- GOSS $1.05
- GCTS $2.71
- Analyst Decision
- GOSS Strong Buy
- GCTS Strong Buy
- Analyst Count
- GOSS 5
- GCTS 1
- Target Price
- GOSS $9.20
- GCTS $8.00
- AVG Volume (30 Days)
- GOSS 963.3K
- GCTS 156.6K
- Earning Date
- GOSS 11-07-2024
- GCTS 11-03-2024
- Dividend Yield
- GOSS N/A
- GCTS N/A
- EPS Growth
- GOSS N/A
- GCTS N/A
- EPS
- GOSS N/A
- GCTS N/A
- Revenue
- GOSS $95,842,000.00
- GCTS $13,398,000.00
- Revenue This Year
- GOSS N/A
- GCTS N/A
- Revenue Next Year
- GOSS N/A
- GCTS $574.68
- P/E Ratio
- GOSS N/A
- GCTS N/A
- Revenue Growth
- GOSS N/A
- GCTS N/A
- 52 Week Low
- GOSS $0.45
- GCTS $2.35
- 52 Week High
- GOSS $1.60
- GCTS $56.00
- Technical
- Relative Strength Index (RSI)
- GOSS 59.72
- GCTS 42.35
- Support Level
- GOSS $0.98
- GCTS $2.68
- Resistance Level
- GOSS $1.09
- GCTS $3.45
- Average True Range (ATR)
- GOSS 0.07
- GCTS 0.19
- MACD
- GOSS 0.01
- GCTS 0.01
- Stochastic Oscillator
- GOSS 74.90
- GCTS 19.89
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About GCTS GCT Semiconductor Holding Inc. Common Stock
GCT Semiconductor Holding Inc. is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.